title: Regulatory systemic effect of postsurgical polychromatic light (480-3400 nm) irradiation of breast cancer patients on the proliferation of tumor and normal cells in vitro.
abstract: OBJECTIVE
  The aim of this work was to study the effect of phototherapy (PT) with percutaneous exposures to polychromatic visible and IR light (pVIS + pIR) on breast cancer (BC) patients at the early postmastectomy period, on the growth-promoting (GP) properties of their blood serum, by evaluating its capability to support proliferation of normal and tumor human cells in vitro.
  
  
  METHODS
  After mastectomy, one group of patients was treated daily for 1 week on the sacral area with pVIS + pIR light (480-3400 nm, 40 mW/cm(2), 95% polarization, 24 J/cm(2)). The second group used as a control was sham irradiated. Blood serum samples collected before surgery, and 1 and 8 days after surgery, were added (2.5%) into nutrition media for cells instead of 10% of fetal calf serum. Cell targets were cultures of human fibroblasts (FBs), keratinocytes (KCs), three lines of the human BC cells (BT-474, HBL-100, Hs 578T) and cells of human epidermoid carcinoma (A-431). Cell number was evaluated by staining cell nuclei with crystal violet and a spectrometric assay of the extracted dye.
  
  
  RESULTS
  The day after mastectomy there were no significant changes in the GP activity of sera. After a 7-day PT course, an increase of this activity was recorded for normal FBs and KCs by 18% and 24%, respectively, in comparison with presurgical levels. GP activity of the same patients' sera for all tumor cells, BT-474, HBL-100, Hs 578T and A-431, decreased by 32%, 17%, 11%, and 7% respectively. As a result, enhancement of proliferation of KCs and FBs and inhibition of proliferation of tumor cells was seen.
  
  
  CONCLUSIONS
  The results suggest an effect at the systemic level where pVIS + pIR light may stimulate growth of human skin cells and simultaneously downregulate the proliferation of tumor cells, including BC cells. This argues in favor of the oncological safety of PT for BC patients postsurgically.
authors.affiliation: 1 Institute of Cytology , Russian Academy of Sciences, St. Petersburg, Russia .
authors.forename: Kira A
authors.initials: KA
authors.lastname: Samoilova
authors.affiliation: 1 Institute of Cytology , Russian Academy of Sciences, St. Petersburg, Russia .
authors.forename: Alexander A
authors.initials: AA
authors.lastname: Zimin
authors.affiliation: 2 Clinical Hospital of the Russian Academy of Sciences , St. Petersburg, Russia .
authors.forename: Anna I
authors.initials: AI
authors.lastname: Buinyakova
authors.affiliation: 3 ABER Institute , Helsinki, Finland .
authors.forename: Anu M
authors.initials: AM
authors.lastname: Makela
authors.affiliation: 1 Institute of Cytology , Russian Academy of Sciences, St. Petersburg, Russia .
authors.forename: Natalia A
authors.initials: NA
authors.lastname: Zhevago
mesh_terms: D001943:Breast Neoplasms / Q000097:blood / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D049109:Cell Proliferation / Q000528:radiation effects*; D002478:Cells, Cultured; D005260:Female; D006801:Humans; D008408:Mastectomy; D008875:Middle Aged; D010789:Phototherapy / Q000379:methods*; D011182:Postoperative Care / Q000379:methods*